Revolution Medicines Inc banner

Revolution Medicines Inc
NASDAQ:RVMD

Watchlist Manager
Revolution Medicines Inc Logo
Revolution Medicines Inc
NASDAQ:RVMD
Watchlist
Price: 154.89 USD 2.2% Market Closed
Market Cap: $30.7B

Wall St Price Targets

RVMD Price Targets Summary
Revolution Medicines Inc

Wall Street analysts forecast RVMD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RVMD is 183.92 USD with a low forecast of 117.16 USD and a high forecast of 276.15 USD.

Lowest Forecast
Price Target
117.16 USD
24% Downside
Average Forecast
Price Target
183.92 USD
19% Upside
Highest Forecast
Price Target
276.15 USD
78% Upside
Revolution Medicines Inc Competitors:
Price Targets
TARA
Protara Therapeutics Inc
442% Upside
WLFC
Willis Lease Finance Corp
24% Upside
CSGP
CoStar Group Inc
59% Upside
QNST
Quinstreet Inc
62% Upside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-63%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-63%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is RVMD's stock price target?
Price Target
183.92 USD

According to Wall Street analysts, the average 1-year price target for RVMD is 183.92 USD with a low forecast of 117.16 USD and a high forecast of 276.15 USD.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett